Clinical Trials Logo
NCT number NCT03362047
Study type Interventional
Source Philipps University Marburg Medical Center
Contact Tello Khodr, MD
Phone +49-(0)641-985-56087
Email Khodr.Tello@innere.med.uni-giessen.de
Status Not yet recruiting
Phase Phase 2
Start date February 1, 2018
Completion date February 1, 2020

Clinical Trial Summary

Pilot study to determine the therapeutic effect of two prarallel groups treated with either Ricuguat or Macitentan, evaluated by the change in systolic and diastolic RV function within 12 weeks after first drug intake in order to plan a larger Phase II study.


Clinical Trial Description

In this multi-center, randomized, open pilot study the therapeutic effect of two prarallel groups treated with either Riciguat or Macitentan shall be determined by evaluating the change in systolic and diastolic RV function within 12 weeks after first drug intake in order to plan a larger Phase II study.The method used to determine the RV function will be the "Conductance Method".


Study Design


Related Conditions & MeSH terms